With the public availability of ChatGPT 3.5 in fall 2022 at the latest, artificial intelligence in the sense of large language models (LLMs) is on everyone’s lips. However, it is often forgotten that this is only the provisional end point of decades of development of artificial intelligence, which, despite its great potential, still has many limitations. The question for practising doctors is how this technology can be used sensibly in everyday clinical practice – and how it should not be used.
Autoren
- Dr. med. Lukas Dürst
- Dr. med. Marc Oertle
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- Genetic Kidney Disease: DOUBLE PROTECT Alport
The SGLT-2 inhibitor dapagliflozin as an add-on to RAS blockade
- Case Study: Cystic Fibrosis in Adults
Recurrent Pneumonia as a Manifestation of Cystic Fibrosis
- Long COVID/Fatigue Clinic
An Innovative Approach: Neuroplasticity and Predictive Processing
- T-cell lymphomas
Diagnostic Challenges and New Treatment Options
- Interbrain Synchrony
Two Brains, One Thought
- Atopic Dermatitis in Children and Adults
Topically Applied “Small Molecules”: Janus Kinases or PDE-4 as Targets?
- Dermatomyositis
Glucocorticoids for more than one year
- The Brain and the Motivation to Eat